Plasma Fibronectin Levels in Clinical Disease States and After Cryoprecipitate Infusion

Summary

Fibronectin levels were measured in 151 hospitalized patients with liver disease, sepsis, malignancy, leukemia, and following trauma or surgery, using heterologous precipitating antibody in an immunoassay. The mean ( ± S.E.M.) in 25 controls was 0.95 ±0.06 U/ml, with females, 0.83 ± 0.07 U/ml, lower than males, 1.09 ± 0.09 U/ml. Mean fibronectin levels were decreased in all disease groups except in obstructive liver disease. The reduced levels in hepatocellular disease and the restoration of levels to normal after orthotopic liver transplantation in patients with hepatocellular disease supports the theory that hepatic synthesis contributes significantly to plasma fibronectin levels. Following cryoprecipitate infusion in four hemophiliac patients, plasma fibronectin levels rose to 32% to 45% of the levels predicted. In patients with reduced fibronectin and poor clinical response to standard treatment (antibiotics, chemotherapy), cryoprecipitate infusions may raise the levels of fibronectin and, perhaps, contribute to clinical improvement.

Key words

Fibronectin - Cryoprecipitate - Liver disease

• References

• 1 Morrison PR, Edsall JT, Miller SG. Preparation and properties of serum and plasma proteins XVIII. The separation of purified fibrinogen from fraction I of human plasma. J Am Chem Soc 1948; 70: 3103-3108
• 2 Saba TM. Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med 1970; 126: 1031-1052
• 3 Yamada KM, Weston JA. Isolation of major cell surface glycoprotein from fibroblasts. Proc Natl Acad Sci USA 1974; 71: 3492-3496
• 4 Pearlstein E. Plasma membrane glycoprotein which mediates adhesion of fibroblasts to collagen. Nature 1976; 262: 497-500
• 5 Hynes RO, Bye JM. Density and cell cycle dependence of cell surface proteins in hamster fibroblasts. Cell 1974; 3: 113-120
• 6 Saba TM, Scovill WA. Effect of surgical trauma on host defense, in Surg Annu. Nyhus LM. (Eds) Appleton-Century-Crofts; NY: 1975. 7 71-102
• 7 Saba TM, Jaffee E. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med 1980; 68: 577-594
• 8 Mosher DF, Williams EM. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729-735
• 9 Blumenstock FA, Saba TM, Weber P. Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay. J Reticuloendothel Soc 1978; 23: 119-134
• 10 Laurell CB. Electroimmunoassay. Scand J Clin Lab Inv 1972; 29: 21-37
• 11 Lewis JH, Spero JA, Hasiba U. Diagnostic methods: Laboratory tests, in Bleeding Disorders. Medical Exam Publishing Co Inc; Garden City, NY: 1978. pp 27-34-37-39
• 12 Stathakis NE, Fountas A, Tsianos E. Plasma fibronectin in normal subjects and in various disease states. J Clin Pathol 1981; 34: 504-508
• 13 Todd HO, Coffee MS, Waalkes TP, Abeloff MD, Parsons RG. Serum levels of fibronectin and a fibronectin-like DNA binding in patients with various diseases. JNCI 1980; 65: 901-904
• 14 Pott G, Meyering M, Voss B, Karges HE, Sieber A. Rapid determination of fibronectin by laser nephelometry: fibronectin concentrations in plasma in human diseases I. J Clin Chem Clin Biochem 1980; 18: 893-895
• 15 Owens MR, Cimino CD. Synthesis of fibronectin by the isolated perfused rat liver. Blood 1982; 59: 1305-1309
• 16 Saba TM, Blumenstock FA, Scovill WA, Bernard H. Cryoprecipi- tate reversal of opsonic α₂-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science 1978; 201: 622-624
• 17 Scovill WA, Saba TM, Blumenstock FA, Bernard H, Powers SR. Opsonic α₂ surface binding glycoprotein therapy during sepsis. Ann Surg 1978; 188: 521-529
• 18 Scovill WA, Annest SJ, Saba TM, Blumenstock FA, Newell JC, Stratton HH, Powers SR. Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surg 1979; 86: 284-293
• 19 Robbins AB, Doran JE, Reese AC, Mansberger AR. Cold insoluble globulin levels in operative trauma: serum depletion, wound sequestration, and biological activity: an experimental and clinical study. Ann Surg 1980; 46: 663-672
• 20 Robbins AB, Doran JE, Reese AC, Mansberger AR. Clinical response to cold insoluble globulin replacement in a patient with sepsis and thermal injury. Am J Surg 1981; 142: 636-638
• 21 Boughton BJ, Simpson A. Plasma fibronectin in acute leukemia. Br J Hematol 1982; 51: 487-491
• 22 Saba TM. Reticuloendothelial systemic host defense after surgery and traumatic shock. Circ Shock 1975; 2: 91-103
• 23 Rennard SI, Crystal RG. Fibronectin in human bronchopulmonary lavage fluid. J Clin Invest 1982; 69: 113-122
• 24 Saba TM. Prevention of liver reticuloendothelial systemic defense failure after surgery by intravenous opsonic glycoprotein therapy. Ann Surg 1978; 188: 142-152